{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:36:00Z","timestamp":1791387360181,"version":"4.3.3"},"reference-count":34,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.1210\/jc.2012-2893","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T02:12:54Z","timestamp":1360289574000},"page":"1022-1030","source":"Crossref","is-referenced-by-count":164,"title":["Predictors of Mortality and Long-term Outcomes in Treated Cushing's Disease: A Study of 346 Patients"],"prefix":"10.1210","volume":"98","author":[{"given":"Jessica K.","family":"Lambert","sequence":"first","affiliation":[{"name":"Division of Endocrinology (J.K.L., E.B.G.), New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levana","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine (L.G., S.F.), New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Fayngold","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine (L.G., S.F.), New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Kostadinov","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (J.K., K.D.P.), Mount Sinai Medical Center, New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalmon D.","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery (J.K., K.D.P.), Mount Sinai Medical Center, New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza B.","family":"Geer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (J.K.L., E.B.G.), New York, New York 10029"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113411227900_B1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113411227900_B2","first-page":"117","article-title":"Incidence and late prognosis of cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932","volume":"2","author":"Cushing","year":"1994","journal-title":"Obes Res"},{"key":"key\n\t\t\t\t2019041113411227900_B4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","article-title":"The natural history of Cushing's syndrome","volume":"13","author":"Plotz","year":"1952","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113411227900_B5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing's syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key\n\t\t\t\t2019041113411227900_B6","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B9","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B12","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113411227900_B15","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/archinte.160.12.1761","article-title":"Association between depression and mortality in older adults: the Cardiovascular Health Study","volume":"160","author":"Schulz","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B16","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/archinte.158.19.2129","article-title":"Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group","volume":"158","author":"Whooley","year":"1998","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00006842-199901000-00003","article-title":"A systematic review of the mortality of depression","volume":"61","author":"Wulsin","year":"1999","journal-title":"Psychosom Med"},{"key":"key\n\t\t\t\t2019041113411227900_B18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing's disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology"},{"key":"key\n\t\t\t\t2019041113411227900_B19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archinte.1981.00340020077021","article-title":"Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels","volume":"141","author":"Starkman","year":"1981","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-1781(86)90096-X","article-title":"Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome","volume":"19","author":"Starkman","year":"1986","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t2019041113411227900_B21","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B22","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's disease","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t2019041113411227900_B24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041113411227900_B25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000064522","article-title":"Chronic hypercortisolemia inhibits dopamine synthesis and turnover in the nucleus accumbens: an in vivo microdialysis study","volume":"76","author":"Pacak","year":"2002","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t2019041113411227900_B26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","article-title":"Long-term negative impact on quality of life in patients with successfully treated Cushing's disease","volume":"61","author":"Heald","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113411227900_B27","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2007.23.3.9","article-title":"National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002","volume":"23","author":"Patil","year":"2007","journal-title":"Neurosurg Focus"},{"key":"key\n\t\t\t\t2019041113411227900_B28","doi-asserted-by":"crossref","first-page":"E1670","DOI":"10.1210\/jc.2011-1317","article-title":"Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature","volume":"96","author":"da Mota","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B29","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113411227900_B30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0889-1591(87)90031-6","article-title":"Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes","volume":"1","author":"Heijnen","year":"1987","journal-title":"Brain Behav Immun"},{"key":"key\n\t\t\t\t2019041113411227900_B31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113411227900_B32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing's syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041113411227900_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing's syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"key":"key\n\t\t\t\t2019041113411227900_B34","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/3\/1022\/10420582\/jcem1022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T08:23:38Z","timestamp":1562660618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/3\/1022\/2536638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2893","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}